Loading...
01/10 17:00
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company reported strong financial performance with record revenues and significant earnings growth, driven by data center and semiconductor markets. Despite some challenges in industrial and medical sectors, strategic acquisitions and product launches are expected to drive future growth. The market strategy and shareholder returns are positive, with substantial stock repurchases and dividend payouts. The Q&A revealed confidence in gaining market share and minimal impact from tariffs. Considering the market cap, the stock price is likely to see a positive movement of 2% to 8% over the next two weeks.
Total Revenue $405,000,000 (up 24% year-over-year); driven by strength in data center computing and semiconductor markets.
Semiconductor Revenue $222,000,000 (up 23% year-over-year); strong demand in AI-related leading edge foundry logic and memory.
Data Center Computing Revenue $96,000,000 (up 30% year-over-year); record revenue driven by multiple new hyperscale programs.
Industrial and Medical Revenue $64,000,000 (down 23% year-over-year); decline due to ongoing channel inventory destocking and lower turns revenue.
Telecom and Networking Revenue $22,000,000 (down 2% year-over-year); decline in line with expectations.
Gross Margin 37.9% (up 280 basis points year-over-year); better than expected due to favorable product mix and improved manufacturing costs.
Operating Income $55,000,000 (up almost 700 basis points year-over-year); driven by revenue growth outpacing operating expense increases.
Earnings Per Share $1.23 (up from $0.58 year-over-year); well above guidance.
Adjusted EBITDA $65,000,000 (more than doubled year-over-year); reflecting strong operational performance.
Cash Flow from Continuing Operations $29,000,000; indicating solid cash generation.
Inventory Days 132 days (up from 126 days in Q4); increase due to adding critical piece part inventories.
Operating Expenses $98,600,000 (down more than $3,000,000 from last quarter); increased modestly year-over-year, well below revenue growth.
CapEx $13,900,000 (3.4% of revenue); reflecting investments in growth.
Dividends Paid $3,800,000; indicating commitment to returning value to shareholders.
Stock Repurchase $22,700,000 worth of common stock at an average price of $83.78 per share; taking advantage of market volatility.
New Product Launches: Strong customer pull for next generation EVOS, Everest, and NavX products, with over 350 qualification units shipped in Q1, a fivefold increase from a year ago.
Design Wins: Multiple design wins in industrial coating, robotics, therapeutic, and life science applications recorded in Q1.
Data Center Revenue: Achieved record revenue of $96 million in Q1, more than doubling year on year, with expectations for continued growth in Q2 and beyond.
Semiconductor Revenue: Revenue of $222 million in Q1, down 2% sequentially but up 23% year over year, with solid demand expected to continue.
Industrial Medical Revenue: Revenue decreased to $64 million in Q1, down 16% sequentially, but expected to recover in Q2 due to increased orders.
Operational Efficiency: Improvements in operational efficiency led to a gross margin of 37.9%, better than expected, with further improvements anticipated from factory consolidation.
Factory Closure: Closure of the last China factory expected to drive further gross margin improvement in the second half of the year.
R&D Investments: Continued heavy investment in R&D, new product capabilities, and digital platform to support growth.
Market Positioning: Strong balance sheet allows for investments in capacity and potential acquisitions to enhance market position.
Tariff Impact: The company acknowledges that while they cannot fully mitigate the direct impact of tariffs, they believe they are relatively well positioned due to their manufacturing footprint in lower tariff countries and compliance with USMCA, which exempts many products from reciprocal tariffs.
Supply Chain Challenges: The company faces ongoing supply chain challenges, particularly in the industrial and medical sectors, where inventory digestion and weaker order turns have negatively impacted revenue.
Economic Uncertainty: There is macroeconomic uncertainty that could impact the pace of recovery in the industrial and medical markets, particularly due to the new tariff regime.
Competitive Pressures: The company is experiencing competitive pressures in the semiconductor market, but they believe their new products and strong customer relationships will help them gain market share.
Customer Demand Visibility: While current customer forecasts support growth, there is limited visibility into macro conditions for the second half of the year, which could affect demand.
Market Dynamics: The industrial and medical markets are experiencing a mixed recovery, with some customers taking a cautious approach due to uncertainties related to tariffs and federal funding.
Acquisition Strategy: The company sees potential for acquisitions in the fragmented industrial and medical markets to gain critical mass and improve their position.
R&D Investments: Continued heavy investment in R&D, new product capabilities, factory consolidation, and digital platform to support customer value.
Product Development: Investments in modular design have reduced development cycle times, enabling rapid delivery of customized solutions.
Factory Closure: Closure of the last China factory expected to drive further gross margin improvement in the second half.
Market Positioning: Broad manufacturing footprint in Malaysia, Philippines, and Mexico allows optimization of production to meet customer needs.
New Product Pipeline: Strong customer pull for next generation EVOS, Everest, and NavX products, with significant increases in qualification units shipped.
Acquisition Strategy: Strong balance sheet enables pursuit of inorganic growth opportunities that create shareholder value.
Q2 Revenue Guidance: Expect revenue in Q2 to grow sequentially, projected at approximately $420 million, plus or minus $20 million.
Gross Margin Guidance: Expect Q2 gross margin to be around 38%.
Operating Expenses Guidance: Expect Q2 operating expenses to increase to $99 million to $101 million.
Full Year Semiconductor Growth: Project semiconductor revenue to grow around 10% for the year.
CapEx Guidance: Increase full year 2025 CapEx guidance to 5% to 6% of revenue.
Long-term Margin Goals: Expect to approach 40% gross margins by the end of the year, with continued improvements in 2026.
Dividends Paid: $3,800,000
Share Repurchase: $22,700,000 worth of common stock repurchased at an average price of $83.78 per share.
Additional Share Repurchase: $908,000 of common stock repurchased at an average price of $94.26 per share.
The earnings call presents a strong growth outlook with a projected 17% revenue growth for 2025, driven by significant increases in data center and semiconductor markets. Despite some unclear responses, the company shows readiness for expansion with new facilities and strategic acquisitions. The positive guidance and strong financial health, alongside a focus on high-margin products and market share gains, suggest a positive stock price movement. However, the market cap indicates a moderate reaction, leading to a 'Positive' prediction of 2% to 8% increase over two weeks.
The earnings call indicates strong financial performance with a 76% YoY EPS increase, improved operating margins, and sustainable revenue growth in data centers. Although semiconductor growth guidance was revised downwards due to tariffs and demand issues, management remains optimistic about revenue levels and future opportunities. The Q&A reveals positive sentiment towards AI data center growth and new product success. The market cap suggests a moderate reaction, leading to a positive stock price prediction of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
